Euro area vs Norway: Cause of death, by non-communicable diseases, female
Euro area
82.6%
in 2021
Norway
87.5%
in 2021
Euro area rank
4th
Norway rank
7th
Cause of death, by non-communicable diseases, female over time
- Euro area
- Norway
How they compare
Norway currently reports 87.5% against 82.6% in Euro area, a difference of 4.9%.
That makes Norway's figure about 1.1 times Euro area's.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Euro area ahead.
Euro area ranks 4th and Norway ranks 7th of 47 groups.
Across the 3 decades both report, Euro area averaged higher in 2 and Norway in 1.
Head to head by decade
| Decade | Euro area | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.3% | 87.2% | 4.1% | Euro area |
| 2010s | 90.8% | 87.5% | 3.3% | Euro area |
| 2020s | 82.7% | 87.3% | 4.6% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Euro area or Norway?
- Norway, at 87.5% against 82.6% in Euro area as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Euro area and Norway?
- 4.9%, with Norway ahead.
- How many years of comparable data are there for Euro area and Norway?
- 6 years are reported by both, from 2000 to 2021.
- How do Euro area and Norway rank globally for cause of death, by non-communicable diseases, female?
- Euro area ranks 4th and Norway ranks 7th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.